TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-06
DOI
10.1038/s41401-019-0280-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP
- (2019) Ying Chen et al. ACTA PHARMACOLOGICA SINICA
- Release and uptake of pathologic alpha-synuclein
- (2018) Veselin Grozdanov et al. CELL AND TISSUE RESEARCH
- Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson’s disease
- (2018) Chen Qiao et al. Journal of Neuroinflammation
- Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP+ )-induced α-synuclein accumulation and neurotoxicity
- (2018) K.-C. Wu et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-synuclein in BV-2 cells
- (2018) Qian-Hang Shao et al. NEUROPHARMACOLOGY
- Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
- (2018) Xian-Si Zeng et al. Frontiers in Aging Neuroscience
- Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
- (2018) Jessika C. Bridi et al. Frontiers in Neuroscience
- Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome
- (2017) Qian-hang Shao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation
- (2017) Jie Qu et al. Journal of Neuroinflammation
- A Novel Bibenzyl Compound (20C) Protects Mice from 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine/Probenecid Toxicity by Regulating the α -Synuclein–Related Inflammatory Response
- (2017) Qiu-Shuang Zhang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Alpha-synuclein activates BV2 microglia dependent on its aggregation state
- (2016) Alana Hoffmann et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
- (2015) A. Gustot et al. BIOCHEMICAL JOURNAL
- Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis
- (2015) Sara OLIVÁN et al. EXPERIMENTAL ANIMALS
- Parkinson’s disease and enhanced inflammatory response
- (2015) Iva Stojkovska et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
- (2015) Sayinthen Vivekanantham et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease
- (2015) Yan Xu et al. JOURNAL OF NEUROCHEMISTRY
- The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
- (2015) Erdinç Dursun et al. JOURNAL OF NEUROIMMUNOLOGY
- Inflammation is genetically implicated in Parkinson’s disease
- (2015) N. Dzamko et al. NEUROSCIENCE
- Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson's Disease
- (2015) J. Drouin-Ouellet et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- (2014) N. Malek et al. ACTA NEUROLOGICA SCANDINAVICA
- Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study
- (2014) Ursula Unterberger et al. CLINICAL NEUROPATHOLOGY
- Caspase-1: The inflammasome and beyond
- (2013) Gabriel Sollberger et al. Innate Immunity
- Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson’s Disease
- (2013) Fabrine S. M. Tristão et al. NEUROTOXICITY RESEARCH
- Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
- (2013) Carmen Noelker et al. Scientific Reports
- An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
- (2012) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
- (2012) Carla M. Lema Tomé et al. MOLECULAR NEUROBIOLOGY
- Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
- (2011) Dawn Béraud et al. PARKINSONISM & RELATED DISORDERS
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic association between α-synuclein and idiopathic parkinson's disease
- (2008) Denise M. Kay et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Expression of TLR4 and CD14 in the Central Nervous System (CNS) in a MPTP Mouse Model of Parkinson's-Like Disease
- (2008) Maria Antonietta Panaro et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
- (2008) Solomon S Shaftel et al. Journal of Neuroinflammation
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started